- Home
- NTNX vs PODD Comparison
NTNX vs PODD Comparison
Compare NTNX & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTNX
- PODD
- Stock Information
- Founded
- NTNX 2009
- PODD 2000
- Country
- NTNX United States
- PODD United States
- Employees
- NTNX N/A
- PODD N/A
- Industry
- NTNX Computer Software: Prepackaged Software
- PODD Medical/Dental Instruments
- Sector
- NTNX Technology
- PODD Health Care
- Exchange
- NTNX Nasdaq
- PODD Nasdaq
- Market Cap
- NTNX 20.5B
- PODD 21.5B
- IPO Year
- NTNX 2016
- PODD 2007
- Fundamental
- Price
- NTNX $75.55
- PODD $291.49
- Analyst Decision
- NTNX Buy
- PODD Strong Buy
- Analyst Count
- NTNX 15
- PODD 19
- Target Price
- NTNX $90.14
- PODD $320.11
- AVG Volume (30 Days)
- NTNX 1.9M
- PODD 561.7K
- Earning Date
- NTNX 08-27-2025
- PODD 08-07-2025
- Dividend Yield
- NTNX N/A
- PODD N/A
- EPS Growth
- NTNX N/A
- PODD 67.46
- EPS
- NTNX 0.09
- PODD 5.55
- Revenue
- NTNX $2,432,612,000.00
- PODD $2,198,900,000.00
- Revenue This Year
- NTNX $19.93
- PODD $24.54
- Revenue Next Year
- NTNX $15.56
- PODD $17.48
- P/E Ratio
- NTNX $839.24
- PODD $52.51
- Revenue Growth
- NTNX 16.11
- PODD 23.48
- 52 Week Low
- NTNX $43.35
- PODD $173.00
- 52 Week High
- NTNX $83.36
- PODD $329.33
- Technical
- Relative Strength Index (RSI)
- NTNX 53.81
- PODD 46.45
- Support Level
- NTNX $73.40
- PODD $284.00
- Resistance Level
- NTNX $76.31
- PODD $294.11
- Average True Range (ATR)
- NTNX 1.72
- PODD 4.72
- MACD
- NTNX 0.07
- PODD 0.60
- Stochastic Oscillator
- NTNX 78.32
- PODD 56.52
About NTNX Nutanix Inc.
Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data, anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company is into a single operating and reportable segment that is subscription-based business model. Key revenue is generated from United States.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.